Search Results - Angela Panoskaltsis‐Mortari
- Showing 1 - 20 results of 100
- Go to Next Page
-
1
3D bioprinting for lungs and hollow organs by Zachary Galliger, Caleb Vogt, Angela Panoskaltsis‐Mortari
Published 2019Revisão -
2
-
3
Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility co... by BR Blazar, PA Taylor, Angela Panoskaltsis‐Mortari, GS Gray, DA Vallera
Published 1995Artigo -
4
-
5
-
6
Rapamycin Inhibits the Generation of Graft-Versus-Host Disease- and Graft-Versus-Leukemia-Causing T Cells by Interfering with the Production of Th1 or Th1 Cytotoxic Cytokines by Bruce R. Blazar, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, Daniel A. Vallera
Published 1998Artigo -
7
-
8
-
9
-
10
-
11
-
12
In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations by Michael Carlson, Michelle L. West, James M. Coghill, Angela Panoskaltsis‐Mortari, Bruce R. Blazar, Jonathan S. Serody
Published 2008Artigo -
13
Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients by Bruce R. Blazar, Byoung S. Kwon, Angela Panoskaltsis‐Mortari, Kyu B. Kwak, Jacques J. Peschon, Patricia A. Taylor
Published 2001Artigo -
14
-
15
-
16
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality by Lisa K. Jasperson, Christoph Bucher, Angela Panoskaltsis‐Mortari, Andrew L. Mellor, David H. Munn, Bruce R. Blazar
Published 2009Artigo -
17
CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or... by Bruce R. Blazar, Patricia A. Taylor, Michael W. Boyer, Angela Panoskaltsis‐Mortari, James P. Allison, Daniel A. Vallera
Published 1997Artigo -
18
-
19
Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. by Bruce R. Blazar, Arlene H. Sharpe, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, G S Gray, Robert Korngold, Daniel A. Vallera
Published 1996Artigo -
20
Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients by Patricia A. Taylor, Michael Ehrhardt, Matthew M. Roforth, Jessica M. Swedin, Angela Panoskaltsis‐Mortari, Jonathan S. Serody, Bruce R. Blazar
Published 2006Artigo
Search Tools:
Related Subjects
Immunology
Biology
Medicine
Internal medicine
Immune system
Graft-versus-host disease
Cancer research
Biochemistry
T cell
Cell biology
Transplantation
In vitro
Stem cell
Genetics
Cytotoxic T cell
Pathology
Receptor
Disease
CD8
Bone marrow
Lung
Antibody
Antigen
Chemistry
Leukemia
Cytokine
Gene
Chemotherapy
Inflammation
Adoptive cell transfer